Trials / Completed
CompletedNCT02248142
Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
Sifrol® (Pramipexole) Impact on RLS: A 12-weeks Observational Study in Patients With Primary RLS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,029 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Study to evaluate treatment effect of pramipexole on RLS severity as measured by IRLS, CGI-I and RLS-6 and to evaluate the time needed to reach maintenance dose of Pramipexole (PPX)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pramipexole |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-01-01
- First posted
- 2014-09-25
- Last updated
- 2014-09-25
Source: ClinicalTrials.gov record NCT02248142. Inclusion in this directory is not an endorsement.